Calamos Global Dynamic Income Fund (CHW) vs abrdn Life Sciences Investors (HQL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 2.8x for Calamos Global Dynamic Income Fund). abrdn Life Sciences Investors offers the higher dividend yield (11.12% vs 7.48%).
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CHW | HQL |
|---|---|---|
| Share price | $8.02 | $17.18 |
| 1-day change | -1.35% | -2.17% |
| YTD return | — | +4.65% |
| 1-year return | — | +11.21% |
| 5-year return | — | -15.00% |
| P/E ratio (TTM) | 2.81 | 2.59 |
| EPS (TTM) | $2.85 | $6.64 |
| Dividend yield | 7.48% | 11.12% |
| Annual dividend | $0.60 | $1.91 |
| 52-week high | $9.18 | $22.67 |
| 52-week low | $6.98 | $15.66 |
| Distance from 52-week high | -12.64% | -24.22% |
| Average volume | 192.89K | 147.31K |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- abrdn Life Sciences Investors offers a meaningfully higher dividend yield (11.12% vs 7.48%).
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
CHW vs HQL FAQ
Which has the lower P/E ratio, CHW or HQL?
HQL has the lower trailing P/E at 2.6, versus 2.8 for CHW. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Calamos Global Dynamic Income Fund or abrdn Life Sciences Investors?
abrdn Life Sciences Investors has the higher yield at 11.12%, compared with 7.48% for Calamos Global Dynamic Income Fund.
Are Calamos Global Dynamic Income Fund and abrdn Life Sciences Investors in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.